A PHASE 1/2 MULTICENTER STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMIS OF BION-1301 IN HEALTHY VOLUNTEERS AND ADULTS WITH IGA NEPHROPATHY
Back
Abstract Number
WCN23-1107
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Other CKD
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
A PHASE 1/2 MULTICENTER STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMIS OF BION-1301 IN HEALTHY VOLUNTEERS AND ADULTS WITH IGA NEPHROPATHY
Co-authors
Kim, S.G.(1);Lee, E.Y.(2);Narayanan, R.(3);Sorensen, B.(4);Schwartz, B.M.(5);King, A.J.(6);Jones-Burton, C.(5);Barratt, J.(7)*;
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Hallym University Sacred Heart Hospital, Nephrology Division, Gyeonggi-Do, South Korea;(2)Soonchunhyang University Cheonan Hospital, Nephrology Division, Cheonan, South Korea;(3)Chinook Therapeutics- Inc, Drug Metabolism And Pharmacokinetics, Seattle, United States;(4)Chinook Therapeutics- Inc, Biometrics, Seattle, United States;(5)Chinook Therapeutics- Inc, Clinical Development, Seattle, United States;(6)Chinook Therapeutics- Inc, Biology, Seattle, United States;(7)University Of Leicester, Department Of Cardiovascular Sciences, Leicester, United Kingdom;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/c214f35975df571e41457f2744b78af7.pdf
Audio File
if any